NCT06161428 Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
| NCT ID | NCT06161428 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rigshospitalet, Denmark |
| Condition | Vulva Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-05-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size \>4 cm, multifocal tumors and local recurrences.
Eligibility Criteria
Inclusion Criteria: * Patients with vulva cancer, tumor \> 4 cm, multifocal tumor, or local recurrences in vulva Exclusion Criteria: * Previous external irradiation of the vulva or groins * Former sentinel node or inguinal lymphadenectomy in the relevant groin * Known allergy to ICG or iodine * Patient is in active treatment for other cancer and/or disseminated disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06161428 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Vulva Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06161428 currently recruiting?
Yes, NCT06161428 is actively recruiting participants. Contact the research team at ligita.paskeviciute.froeding@regionh.dk for enrollment information.
Where is the NCT06161428 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT06161428 clinical trial?
NCT06161428 is sponsored by Rigshospitalet, Denmark. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.